• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 ALIGN® TO URETHRAL SUPPORT SYSTEM - HOOK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 ALIGN® TO URETHRAL SUPPORT SYSTEM - HOOK Back to Search Results
Model Number BRD400HK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Anemia (1706); Erosion (1750); Cellulitis (1768); Cyst(s) (1800); Erythema (1840); Fatigue (1849); Micturition Urgency (1871); Headache (1880); Pyrosis/Heartburn (1883); Hemorrhage/Bleeding (1888); High Blood Pressure/ Hypertension (1908); Incontinence (1928); Inflammation (1932); Nausea (1970); Nerve Damage (1979); Pain (1994); Sepsis (2067); Urinary Retention (2119); Urinary Tract Infection (2120); Vomiting (2144); Burning Sensation (2146); Myalgia (2238); Urinary Frequency (2275); Anxiety (2328); Discomfort (2330); Depression (2361); Fungal Infection (2419); Prolapse (2475); Hematuria (2558); Dysuria (2684); Constipation (3274); Cramp(s) /Muscle Spasm(s) (4521); Skin Inflammation/ Irritation (4545)
Event Type  Injury  
Manufacturer Narrative
The reported event could not be confirmed.No sample was returned for evaluation.Based on the investigation findings, current manufacturing controls are considered adequate as to detect and segregate any non-conforming unit.Event described could not be confirmed as a manufacturing related issue.The alleged event is most likely associated with possible procedural/surgical complications.The ifu currently addresses potential risks associated with surgically implantable materials.Precautions the usual precautions associated with urological procedures should be followed: based on physician experience and training, a thorough assessment of each patient should be made to determine their suitability for the implant procedure.Additional consideration should be given to use of the implant in patients with a compromised immune system, any condition that would compromise healing, or any patient with a history of prior abdominal or pelvic surgeries.Consideration should also be given to the ability of the patient to tolerate the surgical procedure.Accepted surgical practice and precautions must be followed for the management of contaminated or infected wound sites, when the align® to urethral support system is used.Postoperative bleeding may occur in some patients and must be controlled prior to patient release.The implant procedure requires diligent attention to anatomical structures and care to avoid puncture of large vessels, nerves, bladder, bowel, urethra and any viscera, during introducer passage.Due to anatomical distortion that can be caused by pelvic organ prolapse, if the patient requires cystocele repair, it should be performed prior to the implantation of the sub-urethral sling.Proper placement of the sling implant at the mid-urethra requires that it lie flat with minimal or no tension under the urethra.The align® to urethral support system is intended as a single-use device.Do not re-sterilize any portion of the align® to urethral support system.Reuse and/or repackaging may create a risk of patient or user infection, compromise the structural integrity and/or essential material and design characteristics of the device, which may lead to device failure, and/or lead to injury, illness or death of the patient.Patients should be advised that pregnancy following a sling implant procedure may negatively affect the success of the previous implant procedure and incontinence may recur.The safety and effectiveness of the align® to urethral support system implant procedure has not been established for the treatment of stress urinary incontinence in males and children under the age of 18.Cystoscopy can be considered at the physician¿s discretion.Check the integrity of the packaging before use.Do not use the align® to urethral support system if the packaging is opened or damaged.As for any implantable material, it is recommended to open the package at the time of implantation.Post-operatively the patient should be advised to refrain from heavy lifting, exercise (e.G.Cycling, jogging) and/or intercourse until the physician determines it is suitable for the patient to return to normal activities.Adverse events complications associated with the proper implantation of the align® to urethral support system may include, but are not limited to: postoperative hematoma, seroma, abscess or fistula formation, or scarring which may occur following the implant procedure.Urinary retention, bladder outlet obstruction and other voiding dysfunctions.These conditions may be associated with over-correction/too much tension placed on the implant.Perforations or lacerations of vessels, nerves, bladder, bowel, urethra, or any viscera, which may occur during the implantation procedure.Irritation at the operative wound site which may elicit a foreign body response that leads to wound dehiscence, inflammation and/or infection.Extrusion through vaginal epithelium or erosion into surrounding viscera and/or mucosa.Inflammation, sensitization, pain, dyspareunia, scarification, contraction, device migration and failure of the procedure resulting in recurrence of incontinence.(b)(4).
 
Event Description
The patient¿s attorney alleged a deficiency against the device.Additional information has been requested, but not yet received.Product was used for therapeutic treatment.Per additional information received,the patient experienced bladder symptoms, incomplete bladder emptying, fatigue, dysuria, right lower quadrant pain, urethral pain, right inguinal area pain, acute cystitis, sparc mesh erosion into bladder with removal, suprapubic scars, candida infection, abdominal pain, pain on right side with urination, suprapubic pain, urinary frequency up to 20 times per day, urgency incontinence, groin pain when she drives, external irritation, mild erythema along the suture line of the bladder, levator myalgia, overactive bladder, muscle spasm requiring physical therapy, wakes up at night to urinate, difficulty starting urination, straining, weak urinary flow, sensation of incomplete emptying of bowels, bladder infections, vaginal scarring, bleeding and pain with vaginal penetration.Per additional information received, the patient abdominal pain, burning, dysuria, urinary frequency, urinary urgency, hematuria, infection, mesh erosion, mesh extrusion, pelvic pain, radiating pain, recurrence of stress urinary incontinence, urine leakage, left kidney pelviectasis, multiple drug resistant organism/resistant escherichia coli in urine (bacterial infection), urinary tract infection (uti), incomplete bladder emptying (urinary retention), acute cystitis (inflammation), chronic inflammation, foreign body giant cell reaction, right groin/inguinal pain, lower abdominal/urethral discomfort, fatigued, right side pain with voiding, urge incontinence, external irritation, pelvic pressure/heaviness/dullness, leukocytes/protein in urine, abdominal/pelvic floor muscle tenderness, levator myalgia (myalgia), overactive bladder, cold intolerance, nausea, suture line in bladder, muscle spasm, aching, pain with sexual intercourse, increased pelvic floor muscle tension, and required additional surgical and non- surgical interventions.Per additional information received via medical records on (b)(6) 2018, the patient has experienced incomplete bladder emptying, right lower quadrant/inguinal pain and to thigh, pressure and burning to urethra, dysuria, fatigue, urgency, mild pelviectasis of left kidney, recurrent urinary tract infections, acute cystitis, frequency, headaches, pressure and burning in the urethra, nausea, abdominal pain, atrophic vaginitis, (b)(6) 2014 cystoscopy which revealed mesh erosion in the right bladder neck, hematuria, irritated perianal skin, constipation, right suprapubic pain, pain triggered by intercourse, (b)(6) 2014 cystoscopy that reportedly revealed vicryl in the bladder, (b)(6) 2015 cystoscopy that reportedly revealed a small dimple in the bladder, transvaginal ultrasound that reportedly revealed a cystic lesion of the left ovary, pelvic pain, levator myalgia/hypertonicity, intrinsic (urethral) sphincter deficiency, recurrent stress urinary incontinence, small hole in the intestine, candida albicans infection, pudendal neuralgia, use of spinal cord stimulator complicated by infection and hospitalization, endometriosis, entrapped nerve damage, and abdominal adhesions.She has required non-surgical interventions of vaginal estrogen, vaginal valium, diflucan, antibiotics for recurrent urinary tract infections, and physical therapy with poor results.She also required surgical interventions such as excision of eroded sparc mesh ((b)(6) 2014); excision of vaginal tot mesh and cystoscopy ((b)(6) 2015); vaginal exploration, transvaginal urethrolysis, and cystourethroscopy ((b)(6) 2017); and excision of right groin mesh, excision of left groin mesh, excision of vaginal mesh, robotic-assisted laparoscopic excision of abdominal mesh, resection of endometriosis, and kelly plication of urethra ((b)(6) 2018).Per the pfs, the patient also alleged catastrophic pain syndrome, rectal pain, neuralgia, depression, ultrasound guided bilateral pudendal nerve blocks, cystocele, diabetes, pelvic tumors/fibroids, peritonitis/sepsis, urinary retention, and uterine prolapse.Per additional information received via medical record on (b)(6) 2018 the patient has experienced incomplete bladder emptying, right lower quadrant/inguinal pain and to thigh, pressure and burning to urethra, dysuria, fatigue, urgency, mild pelviectasis of left kidney, recurrent urinary tract infections, acute cystitis, frequency, headaches, pressure and burning in the urethra, nausea, abdominal pain, atrophic vaginitis, (b)(6) 2014 cystoscopy which revealed mesh erosion in the right bladder neck, hematuria, irritated perianal skin, constipation, right suprapubic pain, pain triggered by intercourse, (b)(6) 2014 cystoscopy revealed suture line along the right side of the bladder and vicryl visible with some mild erythema, cystoscopies on (b)(6) 2014 and (b)(6) 2014 with normal findings, (b)(6) 2015 ultrasound which revealed a complex cystis lesion in the left ovary, (b)(6) 2015 cystoscopy that revealed a small dimple in the bladder, pelvic pain, rectal pain, levator myalgia/hypertonicity, intrinsic (urethral) sphincter deficiency, recurrent stress urinary incontinence, small hole in the intestine, candida albicans infection, pudendal neuralgia, dyspareunia, urinary incontinence, perineal pain, adjustment disorder with mixed anxiety and depressed mood, ganglion impar block, use of spinal cord stimulator complicated by infection and hospitalization, left flank pain, slow urinary stream and intermittency, endometriosis, entrapped nerve damage, abdominal adhesions, and left leg pain.She has required non-surgical interventions of vaginal estrogen, vaginal valium, diflucan, antibiotics for recurrent urinary tract infections, vesicare, gabapentin, and cymbalta use, and physical therapy with poor results.She also required surgical interventions such as excision of eroded sparc mesh ((b)(6) 2014); trigger point injection ((b)(6) 2015), excision of vaginal tot mesh and cystoscopy ((b)(6) 2015); pudendal nerve blocks x 3, ganglion impar block ((b)(6) 2016), peripheral nerve block and right sided pudendal nerve block ((b)(6) 2016), spinal cord stimulator implantation ((b)(6) 2016), vaginal exploration, transvaginal urethrolysis, and cystourethroscopy ((b)(6) 2017); and excision of right groin mesh, excision of left groin mesh, excision of vaginal mesh, robotic-assisted laparoscopic excision of abdominal mesh, resection of endometriosis, and kelly plication of urethra ((b)(6) 2018).Per the pfs, the patient also alleged catastrophic pain syndrome, cystocele, pelvic tumors/fibroids, peritonitis/sepsis, urinary retention, and uterine prolapse.Per additional information received via medical records on (b)(6) 2022, the patient has experienced stress incontinence, mesh erosion into bladder, stress urinary incontinence, incomplete bladder emptying, acute cystitis, multiple drug resistant organisms, pelvic pain, pudendal neuralgia, lumbar radiculopathy, hirsutism, spasm, lower urinary tract symptoms, adiposity, acne, scar of skin, polycystic ovaries, low back pain, complication of internal prosthetic device, encounter for insertion of intrauterine contraceptive device, hip pain, infection or inflammation of bladder, overweight, allergy, infection of spinal cord stimulator, insomnia, dysuria, urgency, frequency, hematuria, flank pain, malaise/fatigue, hypertension, constipation, heartburn, myalgias, sensory change, depression, rectal pain, vaginal pain, groin pain, cellulitis of lower back, nausea with vomiting, dyspepsia, levator myalgia/ hypertonicity, helicobacter pylori infection, sphincter deficiency, microscopic hematuria, gastroesophageal reflux disease, anemia, genitourinary disease, anxiety, headache, high blood pressure, high cholesterol, pruritus ani, hemorrhage of rectum and anus, dermatophytosis of groin and perianal area, hypovitaminosis d, migraines, hyperlipidemia, reflux esophagitis, candida albicans infection, atrophic vaginitis, vaginal discharge and required additional surgical and non-surgical interventions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALIGN® TO URETHRAL SUPPORT SYSTEM - HOOK
Type of Device
ALIGN® TO URETHRAL SUPPORT SYSTEM - HOOK
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
juan velez
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key15066697
MDR Text Key296244035
Report Number1018233-2022-90020
Device Sequence Number1
Product Code OTN
UDI-Device Identifier00801741016219
UDI-Public(01)00801741016219
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K093747
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 07/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2014
Device Model NumberBRD400HK
Device Catalogue NumberBRD400HK
Device Lot NumberHUWH1797
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Device Age13 MO
Event Location Hospital
Initial Date Manufacturer Received 07/01/2022
Initial Date FDA Received07/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/27/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN.
Patient Outcome(s) Required Intervention;
Patient Age34 YR
Patient SexFemale
Patient Weight73 KG
Patient RaceWhite
-
-